Recent developments in the startup landscape include notable funding rounds and acquisitions, particularly among AI-powered platforms in sustainability and biotechnology. London-based Leafr has raised approximately €726K to enhance its AI-driven sustainability marketplace, while Ignota Labs secured nearly €6.66M to fuel its clinical drug development efforts. Other startups like Salvus Health are also attracting investment to expand their operations in Europe. These financing events signal a robust interest in innovative technologies aimed at addressing urgent climate and healthcare challenges.
London-based Leafr has closed an oversubscribed £600K (approximately €726K) funding round to enhance its AI-driven sustainability marketplace and expand its network of over 1,000 vetted specialists.
The funding will support the acquisition of additional distressed drug assets and advance early-stage clinical trials for its first asset, a PDE9A inhibitor.
Collection
[
|
...
]